Health X Platform promoter Ravi Kant Sharma sells shares worth Rs. 7.5 crore
Health X Platform Limited disclosed that promoter Ravi Kant Sharma sold 2,50,000 equity shares on June 3, 2026, for Rs. 7,49,77,528.94 via market sale. Post-transaction, his shareholding stands at 7,47,393 shares, or 2.35% of the capital.

*this image is generated using AI for illustrative purposes only.
Health X Platform Limited disclosed that promoter Ravi Kant Sharma sold 2,50,000 equity shares on June 3, 2026, reducing his stake in the company. The transaction, executed via a market sale, was valued at Rs. 7,49,77,528.94. This sale was conducted under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, which mandates the disclosure of changes in shareholding by promoters.
Prior to the disposal, Sharma held 9,97,393 shares, accounting for 3.14% of the company's capital. Following the sale on June 3, 2026, his holding has decreased to 7,47,393 shares, which now represents 2.35% of the share capital. The company intimated the stock exchanges regarding this transaction on June 4, 2026.
Details of Transaction
The disclosure was submitted to BSE Ltd. and the National Stock Exchange of India Ltd. The following table summarizes the change in the promoter's shareholding:
| Parameter | Details |
|---|---|
| Name of Promoter | Ravi Kant Sharma |
| Category | Promoter |
| Securities Sold | Equity Shares |
| Number of Shares Sold | 2,50,000 |
| Sale Value | Rs. 7,49,77,528.94 |
| Mode of Disposal | Market Sale |
| Date of Sale | 03.06.2026 |
| Pre-sale Holding | 9,97,393 shares (3.14%) |
| Post-sale Holding | 7,47,393 shares (2.35%) |
The company confirmed that there were no trades in derivatives by the promoter during this period. The filing was signed by Pratap Singh, Company Secretary & Compliance Officer of Health X Platform Limited.
Historical Stock Returns for Health X Platform
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.45% | -2.74% | -2.45% | -4.84% | +2.97% | +22.47% |
Does this reduction in promoter stake signal a potential shift in the company's strategic direction or management focus?
How might the market interpret this significant sale by a promoter regarding future valuation and investor confidence?
Are there plans for other promoters or key management personnel to adjust their holdings in the near future?


































